Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Broker Notes
Analysts name 3 ASX shares to sell now
Healthcare Shares
This biotechnology stock just ticked over 100% gains for the month on more good news
Healthcare Shares
See which junior ASX biotech is rocketing 63% higher on good news
Healthcare Shares
2 ASX healthcare shares outperforming peers on positive company news
Cheap Shares
5 potentially cheap ASX shares being bought by insiders
Healthcare Shares
3 ASX healthcare shares up 10% to 22% on news
Share Gainers
Why Delta Lithium, Liontown, Pact, and Starpharma shares are storming higher
Healthcare Shares
Here's why the Starpharma share price just exploded 50%!
Earnings Results
4 ASX healthcare shares charging higher on positive earnings updates
Share Fallers
Why IGO, Patriot Battery Metals, Silver Lake, and Starpharma shares are sinking today
Healthcare Shares
Why is this ASX All Ords share sinking 34% on Monday?
Share Fallers
Why Legend Mining, Medibank, Starpharma, and Weebit Nano shares are sinking
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.